Paolo Tarantino (@ptarantinomd) 's Twitter Profile
Paolo Tarantino

@ptarantinomd

MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. SoMe Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.

ID: 958742483856486400

calendar_today31-01-2018 16:43:15

13,13K Tweet

26,26K Followers

651 Following

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo
Paolo Tarantino
@ptarantinomd

2 months ago

>90% of the patients with HR+ mBC are eligible for T-DXd, a life prolonging drug Many, however, are still not recognized as eligible due to issues with HER2 testing (no IHC performed, no dissection of ultralow/null) In our latest review, we dive deep into this important topic👇